SPUR THERAPEUTICS LIMITED

Active Private Limited Company Incorporated 19 Mar 2015

Checks

1 to look at 9 clear · 4 can't tell yet

Look
Charges
4 outstanding: a lender holds security over its assets and is paid first if it fails.
Companies House register

The other 13 checks

Can't tell
Disqualified directors
No current officers to check yet.
Companies House disqualified directors register · What this means
Can't tell
Directors
Officers are still being fetched from Companies House.
Officers on the register · What this means
Can't tell
Owners
None on file yet: the owners file is still being loaded.
People with significant control · See it · What this means
Can't tell
Last filed accounts
No figures held. They come from accounts filed online since October 2025.
Filed accounts · See it · What this means
Clear
Company status
Active.
Companies House register
Clear
Insolvency
No insolvency cases or filings.
Companies House insolvency record and filing history
Clear
Strike-off notices
No strike-off notice in the last three years.
Filing history (The Gazette notices) · See it
Clear
Accounts on time
Next due 30 Sep 2027.
Companies House register
Clear
Confirmation statement on time
Next due 2 Apr 2027.
Companies House register
Clear
Trading history
Incorporated 19 Mar 2015 (11 years ago).
Companies House register
Clear
Name changes
2 earlier names, none in the last year.
Names over time
Clear
Year-end changes
Not changed in three years.
Filing history (form AA01) · See it
Clear
Office moves
Not moved in two years.
Filing history (form AD01) · See it

From the public register, filing history, officers, owners and filed accounts, as of 26 Oct 2026. Not a credit score or advice: open the filings before relying on them. JSON

Registered office

Sycamore House, Gunnels Wood Road, Stevenage, Hertfordshire, England, SG1 2BP
As filed with Companies House.
Nature of business
- 72110 Research and experimental development on biotechnology
Accounts

Next due
30 Sep 2027

Last made up to
31 Dec 2025

Type
AUDIT EXEMPTION SUBSIDIARY
Confirmation statement

Next due
2 Apr 2027

Last made up to
19 Mar 2026
Charges

Outstanding
4

All time
9
Names
1. SPUR THERAPEUTICS LIMITED 27 Sep 2024 – now
2. FREELINE THERAPEUTICS LIMITED 7 Dec 2015 – 27 Sep 2024
3. NEWINCCO 1354 LIMITED 19 Mar 2015 – 7 Dec 2015

Figures

Chart

No figures held yet. They come from accounts filed online since October 2025, and the year before shown in them.

People

Officers

Fetching them from Companies House. They appear here within a few minutes.

Owners and controllers All 5, with past →

None on file.

From the public register. We show month and year of birth only, and no addresses. Privacy and your data

Ask about this company

Questions

Is SPUR THERAPEUTICS LIMITED still trading?

The register shows SPUR THERAPEUTICS LIMITED as active.

What does SPUR THERAPEUTICS LIMITED do?

It files the industry code 72110 (Research and experimental development on biotechnology).

When was SPUR THERAPEUTICS LIMITED set up?

It was incorporated on 19 March 2015.

When are SPUR THERAPEUTICS LIMITED's accounts due?

Next accounts are due by 30 September 2027. The last accounts were made up to 31 December 2025.

When is SPUR THERAPEUTICS LIMITED's next confirmation statement due?

By 2 April 2027.

Similar companies

Same industry code (72110), active, set up around the same time. More in this industry →

The file

3 of 3 free downloads left today · Last 5 years' accounts as one zip (1 credit a PDF)

Date	Form	Description	Pages	Document
25 Oct 2026	AA	Accounts (audit exemption subsiduary), made up to 31 Dec 2025		paper
25 Oct 2026	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/25		paper
25 Oct 2026	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/25		paper
25 Oct 2026	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/25		paper
20 Aug 2026	AP01	Director appointed: Henning Stennicke	2	PDF ↓
18 Aug 2026	TM01	Director left: Michael John Parini	1	PDF ↓
3 Jul 2026	CH01	Director's details changed: Paul Schneider	2	PDF ↓
3 Jul 2026	CH01	Director's details changed: James Bircher	2	PDF ↓
3 Jul 2026	CH01	Director's details changed: Mr Michael John Parini	2	PDF ↓
28 Mar 2026	CS01	Confirmation statement, with changes, made up to 19 Mar 2026	4	PDF ↓
26 Mar 2026	PSC07	Person with significant control removed	1	PDF ↓
26 Mar 2026	PSC02	Person with significant control added	2	PDF ↓
9 Oct 2025	AA	Accounts (audit exemption subsiduary), made up to 31 Dec 2024	19	PDF ↓
9 Oct 2025	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/24	50	PDF ↓
9 Oct 2025	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/24	3	PDF ↓
9 Oct 2025	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/24	1	PDF ↓
2 Oct 2025	MR01	Charge created	7	PDF ↓
3 Jun 2025	MR01	Charge created	7	PDF ↓
17 Apr 2025	MR01	Charge created	7	PDF ↓
26 Mar 2025	CS01	Confirmation statement, no changes, made up to 19 Mar 2025	3	PDF ↓
11 Feb 2025	MR04	Charge satisfied	1	PDF ↓
27 Sep 2024	CERTNM	Company name changed freeline therapeutics LIMITED\certificate issued on 27/09/24	3	PDF ↓
27 Aug 2024	MR04	Charge satisfied	1	PDF ↓
22 Aug 2024	MR04	Charge satisfied	1	PDF ↓
22 Aug 2024	MR04	Charge satisfied	1	PDF ↓
15 Jul 2024	AA	Accounts (audit exemption subsiduary), made up to 31 Dec 2023	21	PDF ↓
15 Jul 2024	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/23	64	PDF ↓
15 Jul 2024	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/23	3	PDF ↓
15 Jul 2024	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/23	1	PDF ↓
26 Apr 2024	AD04	Move registers to registered office company with new address	1	PDF ↓
26 Apr 2024	CS01	Confirmation statement, no changes, made up to 19 Mar 2024	3	PDF ↓
23 Jan 2024	MR01	Charge created	79	PDF ↓
13 Dec 2023	MR01	Charge created	78	PDF ↓
24 Nov 2023	AA	Accounts (full), made up to 31 Dec 2022	23	PDF ↓
23 Nov 2023	MR01	Charge created	62	PDF ↓
21 Mar 2023	CS01	Confirmation statement, no changes, made up to 19 Mar 2023	3	PDF ↓
15 Mar 2023	AD02	Change sail address company with old address new address	1	PDF ↓
30 Dec 2022	PSC05	Change to a person with significant control	2	PDF ↓
16 Dec 2022	AD01	Registered office changed	1	PDF ↓
1 Oct 2022	AA	Accounts (full), made up to 31 Dec 2021	23	PDF ↓
18 Jul 2022	AP01	Director appointed: James Bircher	2	PDF ↓
15 Jul 2022	TM01	Director left: Stephen Patrick Diamond Jr	1	PDF ↓
6 Jun 2022	AP01	Director appointed: Paul Schneider	2	PDF ↓
6 Jun 2022	TM01	Director left: Amy Spandau	1	PDF ↓
11 Apr 2022	AP01	Director appointed: Amy Spandau	2	PDF ↓
5 Apr 2022	TM01	Director left: Benjamin Charles George Warriner	1	PDF ↓
28 Mar 2022	AD02	Change sail address company with old address new address	1	PDF ↓
25 Mar 2022	CS01	Confirmation statement, with changes, made up to 19 Mar 2022	5	PDF ↓
3 Oct 2021	AA	Accounts (full), made up to 31 Dec 2020	23	PDF ↓
20 Sep 2021	SH01	Shares allotted	4	PDF ↓

Source: Companies House and its live updates. View on Companies House

SPUR THERAPEUTICS LIMITED

Checks

Registered office

Nature of business

Accounts

Confirmation statement

Charges

Names